G209A mutant alpha synuclein expression specifically enhances dopamine induced oxidative damage

Neurochemistry International

Volumn 45, Issue 5, 2004, Pages 669-676

  Orth, M ^a,b   Tabrizi, S J ^a,b   Tomlinson, C ^a   Messmer, K ^a   Korlipara, L V P ^a   Schapira, A H V ^a,b   Cooper, J M ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alpha synuclein; Dopamine toxicity; Oxidative stress

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; GLUTATHIONE; MONOAMINE; PARAQUAT; RESERPINE;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; MUTANT; NEUROPATHOLOGY; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

EID: 3042541863     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2004.03.029     Document Type: Article

References (47)

1. Abeliovich A., Schmitz Y., Fariñas I., Choi-Lundberg D., Ho W.S., Castillo P.E., Shinsky N., Verdugo J.M.G., Armanini M., Ryan A., Hynes M., Phillips H., Sulzer D., Rosenthal A. Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron. 25:2000;239-252
2. Betarbet R., Sherer T.B., Mackenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3:2000;1301-1306
3. Beal M.F. Experimental models of Parkinson's disease. Nat. Rev. Neurosci. 2:2001;325-334
4. Berman S.B., Hastings T.G. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J. Neurochem. 73:1999;1127-1137
5. Burton L.D., Kippenberger A.G., Lingen B., Bruss M., Bonisch H., Christie D.L. A variant of the bovine noradrenaline transporter reveals the importance of the C-terminal region for correct targeting to the membrane and functional expression. Biochem. J. 330:1998;909-914
6. Conway K.A., Rochet J.C., Bieganski R.M., Lansbury P.T. Kinetic stabilization of the a-synuclein protofibril by a dopamine-a-synuclein adduct. Science. 294:2001;1346-1349
7. Eshleman A.J., Stewart E., Evenson A.K., Mason J.N., Blakely R.D., Janowsky A., Neve K.A. Metabolism of catecholamines by catechol-O- methyltransferase in cells expressing recombinant catecholamine transporters. J. Neurochem. 69:1997;1459-1466
8. Gardner P.R., Nguyen D.D.H., White C.W. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc. Natl. Acad. Sci. U.S.A. 91:1994;12248-12252
9. Giasson B.I., Duda J.E., Murray I.V., Chen Q., Souza J.M., Hurtig H.I., Ischiropoulos H., Trojanowski J.Q., Lee V.M. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 290:2000;985-989
10. Goldstein M., Fuxe K., Hokfelt T. Characterization and tissue localization of catecholamine synthesizing enzymes. Pharmacol. Rev. 24:1972;293-309
11. Graham D.G. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14:1978;633-643
12. Gründemann D., Koster S., Kiefer N., Breidert T., Engelhardt M., Spitzenberger F., Obermuller N., Schomig E. Transport of monoamine transmitters by the organic cation transporter type 2, OCT2. J. Biol. Chem. 273:1998;30915-30920
13. Hasegawa E., Takeshige K., Oishi T., Murai Y., Minikami S. 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidtaion in bovine heart submitochondrial particles. Biochem. Biophys. Res. Commun. 170:1990;1049-1055
14. Hausladen A., Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J. Biol. Chem. 269:1994;29405-29408
15. Hirai K., Ikeda K., Wang G.Y. Paraquat damage of rat liver mitochondria by superoxide production depends on extramitochondrial NADH. Toxicology. 72:1992;1-16
16. Hsu L.J., Sagara Y., Arroyo A., Rockenstein E., Sisk A., Mallory M., Wong J., Takenouchi T., Hashimoto M., Masliah E. α-synuclein promotes mitochondrial deficit and oxidative stress. Am. J. Pathol. 157:2000;401-410
17. Hussain T., Lokhandwala M.F. Renal dopamine receptor function in hypertension. Hypertension. 32:1998;187-197
18. Irizarry M.C., Kim T.W., McNamara M., Tanzi R.E., George J.M., Clayton D.F., Hyman B.T. Characterization of the precursor protein of the non A beta component of senile plaques (NACP) in the human central nervous system. J. Neuropathol. Exp. Neurol. 55:1996;889-895
19. Jensen P.H., Nielsen M.S., Jakes R., Dotti C.G., Goedert M. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J. Biol. Chem. 273:1998;26292-26294
20. Junn E., Mouradian M.M. Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine. Neurosci. Lett. 320:2002;146-150
21. Kanda S., Bishop J.F., Eglitis M.A., Yang Y., Mouradian M.M. Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation. Neuroscience. 97:2000;279-284
22. Kholodilov N.G., Neystat M., Oo T.F., Larsen K.E., Sulzer D., Burne R.E. Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury. J. Neurochem. 73:1999;2586-2599
23. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 392:1998;605-608
24. Ko L., Mehta N.D., Farrer M., Easson C., Hussey J., Hardy J., Yen S.C. Sensitization of neuronal cells to oxidative stress with mutated human α-synuclein. J. Neurochem. 75:2000;2546-2554
25. Lindvall O., Bjorklund A. The glyoxylic acid fluorescence histochemical method: a detailed account of the methodology for the visualization of central catecholamine neurons. Histochemistry. 39:1974;97-127
26. Lotharius J., Barg S., Wiekop P., Lundberg C., Raymon H.K., Brundin P. Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J. Biol. Chem. 277:2002;38884-38894
27. Luo Y., Roth G.S. The roles of dopamine oxidative stress and dopamine receptor signalling in aging and age-related neurodegeneration. Antioxidants Redox Signaling. 2(3):2000;449-460. (Mary Ann Liebert Inc.)
28. Manning-Bog A.B., McCormack A.L., Li J., Uversky V.N., Fink A.L., Di Monte D.A. The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice. J. Biol. Chem. 277:2002;1641-1644
29. Manning-Bog A.B., McCormack A.L., Purisai M.G., Bolin L.M., Di Monte D.A. Alpha synuclein overexpression protects against paraquat-induced neurodegeneration. J. Neurosci. 23:2003;3095-3099
30. Murphy D.D., Rueter S.M., Trojanowski J.Q., Lee V.M.Y. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. Neurosci. 20:2000;3214-3220
31. Okada T., Shimada S., Sato K., Kotake Y., Kawai H., Ohta S., Tohyama M., Nishimura T. Tetrahydropapaveroline and its derivatives inhibit dopamine uptake through dopamine transporter expressed in HEK293 cells. Neurosci. Res. 30:1998;87-90
32. Olanow C.W., Tatton W.G. Etiology and pathogenesis of Parkinson's disease. Ann. Rev. Neurosci. 22:1999;123-144
33. Parti R., Ozkan E.D., Harnadek G.J., Njus D. Inhibition of norepinephrine transport and reserpine binding by reserpine derivatives. J. Neurochem. 48:1987;949-953
34. Patel M., Day B.J., Crapo J.D., Fridovich I., McNamara J.O. Requirement for superoxide in excitotoxic cell death. Neuron. 16:1996;345-355
35. Paxinou E., Chen Q., Weisse M., Giasson B.I., Norris E.H., Rueter S.M., Trojanowski J.Q., Lee V.M., Ischiropoulos H. Induction of alpha-synuclein aggregation by intracellular nitrative insult. J. Neurosci. 21:2001;8053-8061
36. Perez R.G., Waymire J.C., Lin E., Liu J.J., Guo F., Zigmond M.J. A role for alpha-synuclein in the regulation of dopamine biosynthesis. J. Neurosci. 15:2002;3090-3099
37. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047
38. Sanchez-Ramos J., Övervik E., Ames B.N. A marker of oxydoradical-mediated DNA damage (8-hydroxy-2′deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain. Neurodegeneration. 3:1994;197-204
39. Shimada H., Hirai K., Simamura E., Pan J. Mitochondrial NADH-quinone oxidoreductase of the outer membrane is responsible for paraquat cytotoxicity in rat livers. Arch. Biochem. Biophys. 351:1998;75-81
40. Shimura-Miura H., Hattori N., Kang D., Miyako K., Nakabeppu Y., Mizuno Y. Increased 8-oxo-dGTPase in the mitochondria of substantia nigra neurons in Parkinson's disease. Ann. Neurol. 46:1999;920-924
41. Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K., Suzuki T. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25:2000;302-305
42. Shimura H., Hattori N., Kubo S., Yoshikawa M., Kitada T., Matsumine H., Asakawa S., Minoshima S., Yamamura Y., Shimizu N., Mizuno Y. Immunohistochemical and subcellular loaclization of parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients. Ann. Neurol. 45:1999;668-672
43. Sian J., Dexter D.T., Lees A.J., Daniel S., Agid Y., Jenner P., Marsden C.D. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36:1994;348-355
44. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature. 388:1997;839-840
45. Tabrizi S.J., Orth M., Wilkinson M., Taanman J.W., Warner T.T., Cooper J.M., Schapira A.H.V. Expression of mutant α-synuclein causes increased susceptibility to dopamine toxicity. Hum. Mol. Genet. 9:2000;2683-2689
46. Sidhu A. Attenuation of dopamine transporter activity by alpha-synuclein. Neurosci. Lett. 340(3):2003;189-192
47. Xu J., Kao S.Y., Lee F.J., Song W., Jin L.W., Yankner B.A. Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat. Med. 8:2002;600-606